A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families. Issue 2 (22nd November 2017)

• Record Type: Journal Article
• Authors: Kimble, Danielle C.; Lach, Francis P.; Gregg, Siobhan Q.; Donovan, Frank X.; Flynn, Elizabeth K.; Kamat, Aparna; Young, Alice; Vemulapalli, Meghana; Thomas, James W.; Mullikin, James C.; Auerbach, Arleen D.; Smogorzewska, Agata; Chandrasekharappa, Settara C.
• Is Part Of: Human mutation. Volume 39:Issue 2(2018)
• Page Start: 237
• Page End: 254
• Publication Date: 2017-11-22
• Subjects: Fanconi anemia -- FANCA -- functional assay -- pathogenic mutations -- recessive disorder; Human chromosome abnormalities -- Periodicals; Mutation (Biology) -- Periodicals; 616.04205
• DOI: 10.1002/humu.23366
• Languages: English
• ISSNs: 1059-7794

Abstract

Abstract: Fanconi anemia (FA) is a rare recessive DNA repair deficiency resulting from mutations in one of at least 22 genes. Two‐thirds of FA families harbor mutations in FANCA . To genotype patients in the International Fanconi Anemia Registry (IFAR) we employed multiple methodologies, screening 216 families for FANCA mutations. We describe identification of 57 large deletions and 261 sequence variants, in 159 families. All but seven families harbored distinct combinations of two mutations demonstrating high heterogeneity. Pathogenicity of the 18 novel missense variants was analyzed functionally by determining the ability of the mutant cDNA to improve the survival of a FANCA ‐null cell line when treated with MMC. Overexpressed pathogenic missense variants were found to reside in the cytoplasm, and nonpathogenic in the nucleus. RNA analysis demonstrated that two variants (c.522G > C and c.1565A > G), predicted to encode missense variants, which were determined to be nonpathogenic by a functional assay, caused skipping of exons 5 and 16, respectively, and are most likely pathogenic. We report 48 novel FANCA sequence variants. Defining both variants in a large patient cohort is a major step toward cataloging all FANCA variants, and permitting studies of genotype–phenotype correlations. Abstract : This study identifies the two disease‐causing FANCA variants in each of 159 Fanconi anemia (FA) patients. Nearly all the patients had a distinct set of mutations demonstrating a huge genetic heterogeneity. The sequence variants causing changes in the encoded protein (top), along with intronic splicing variants (bottom), account for 77% of the pathogenic variants, while the remaining 23% are large deletions.